Video

The Future of Specialty Pharmacy Accreditation

Matthew Hughes, director of Business Development for the Accreditation Commission for Health Care (ACHC), discusses developments for ACHC in the pharmacy accreditation space.

Matthew Hughes, director of Business Development for the Accreditation Commission for Health Care (ACHC), discusses developments for ACHC in the pharmacy accreditation space.

Related Videos
3D rendering of multiple myeloma cancer cells | Image Credit: © Сергей Косилко - stock.adobe.com
fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com
Patient receiving diabetes consultation -- Image credit: Syda Productions | stock.adobe.com
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Related Content
Man with Alzheimer disease taking brain supplements -- Image credit: Syda Productions | stock.adobe.com
February 12th 2025

Pharmacists Can Recommend Supplements and Lifestyle Modifications for Patients With Alzheimer Disease

Gillian McGovern, Associate Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Target cells with abnormal red blood cells in blood smear, specimen from thalassemia patient, analyze by microscope 1000x
February 11th 2025

For Pharmacists Treating Thalassemia, Monitoring Anemia and Proper Counseling on Therapies is Crucial

Luke Halpern, Assistant Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Machine learning and AI -- Image credit: everythingpossible | stock.adobe.com
February 9th 2025

Machine Learning Shows Promise Predicting Progression of CKD to Kidney Failure

Gillian McGovern, Associate Editor
Nipocalimab Demonstrates Sustained Disease Control, Reduction in Autoantibodies in Generalized Myasthenia Gravis
February 8th 2025

Nipocalimab Demonstrates Sustained Disease Control, Reduction in Autoantibodies in Generalized Myasthenia Gravis

Luke Halpern, Assistant Editor